Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2020

Open Access 01-12-2020 | Streptococci | Case report

Facklamia hominis bacteremia after transurethral resection of the prostate: a case report

Authors: Miriam Gahl, Thomas Stöckli, René Fahrner

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

Transurethral resection of the prostate (TUR-P) is one of the most frequent routine procedures in urology. Because of the semisterile environment, postoperative infections, including sepsis, are a common complication, with Escherichia coli, Klebsiella spp., Proteus mirabilis or Enterococcus faecalis as frequently isolated pathogens. Facklamia hominis is a gram-positive, facultatively anaerobic, alpha-hemolytic, catalase-negative coccus that was first described in 1997. To date, only a few cases of infectious complications have been described. We report the first case of postoperative bacteremia due to Facklamia hominis after TUR-P.

Case presentation

An 82-year-old man developed fever only a few hours after elective TUR-P because of benign prostate syndrome. After cultivation of blood cultures, antibiotic therapy with ceftriaxone was intravenously administered and changed to oral cotrimoxazole before discharge of the afebrile patient. One anaerobic blood culture revealed Facklamia hominis. Under antibiotic therapy, the patient remained afebrile and showed no signs of infections during follow-up.

Conclusions

Fever and bacteremia are frequent complications after TUR-P. This study is the first report of Facklamia hominis in a postoperative blood culture after TUR-P. To date, there are only a few reports of patients with infectious complications and isolation of Facklamia hominis in various patient samples. Because Facklamia hominis resembles viridans streptococci on blood agar analysis, this pathogen may often be misidentified. In this case identification of Facklamia hominis was possible with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. It has been postulated that Facklamia hominis might be a facultative pathogen and that its incidence will increase in the future.
Literature
1.
Schneidewind L, Kranz J, Schlager D, Barski D, Muhlsteadt S, Grabbert M, Queissert F, Frank T, Pelzer AE. Mulitcenter study on antibiotic prophylaxis, infectious complications and risk assessment in TUR-P. Central Eur J Urol. 2017;70(1):112–7.
2.
Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG, Working group “urological infections” of German Society of U. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur Urol. 2005;47(4):549–56.CrossRef
3.
Schmiedl S, Thurmann PA, Roth S. Antibiotic prophylaxis for patients with transurethral resection of the prostate (TUR-P). Der Urol Ausg A. 2009;48(1):66–72.CrossRef
4.
Berry A, Barratt A. Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol. 2002;167(2 Pt 1):571–7.PubMed
5.
6.
7.
Corona PS, Haddad S, Andres J, Gonzalez-Lopez JJ, Amat C, Flores X. Case report: first report of a prosthetic joint infection caused by Facklamia hominis. Diagn Microbiol Infect Dis. 2014;80(4):338–40.CrossRef
8.
Collins MD, Falsen E, Lemozy J, Akervall E, Sjoden B, Lawson PA. Phenotypic and phylogenetic characterization of some Globicatella-like organisms from human sources: description of Facklamia hominis gen. Nov., sp. nov. Int J Syst Bacteriol. 1997;47(3):880–2.CrossRef
9.
Parvataneni KC, Iyer S, Khatib R, Saravolatz LD. Facklamia Species and Streptococcus pneumoniae Meningitis: A Case Report and Review of the Literature. Open forum Infect Dis. 2015;2(2):ofv029.CrossRef
10.
Healy B, Beukenholt RW, Tuthill D, Ribeiro CD. Facklamia hominis causing chorioamnionitis and puerperal bacteraemia. J Infect. 2005;50(4):353–5.CrossRef
11.
Safavi S, Tufnell M, Bhalla A. Multi-territory ischaemic strokes and subacute bacterial endocarditis. BMJ Case Rep. 2010;2010.
12.
Schlipkoter M, Grieser T, Forst H. Unusual complication following placement of an epidural catheter. Anaesthesist. 2017;66(7):506–10.CrossRef
13.
Gomez-Luque JM, Foronda-Garcia-Hidalgo C, Gutierrez-Fernandez J. Balanopostitis by Facklamia hominis in pediatrics. Revista espanola de quimioterapia. 2019;32(3):278–80.PubMedPubMedCentral
14.
Mostafa HH, Taffner SM, Wang J, Malek A, Hardy DJ, Pecora ND. Genome sequence of a Facklamia hominis isolate from a patient with Urosepsis. Microbiol Resource Announcements. 2019;8(17).
15.
Abat C, Garcia V, Rolain JM. Facklamia hominis scapula abscess, Marseille, France. New Microbes New Infect. 2016;9:13–4.CrossRef
16.
Ananthakrishna R, Shankarappa RK, Jagadeesan N, Math RS, Karur S, Nanjappa MC. Infective endocarditis: a rare organism in an uncommon setting. Case Rep Infect Dis. 2012;2012:307852.PubMedPubMedCentral
17.
Collins MD, Lawson PA, Monasterio R, Falsen E, Sjoden B, Facklam RR. Facklamia ignava sp. nov., isolated from human clinical specimens. J Clin Microbiol. 1998;36(7):2146–8.CrossRef
18.
Collins MD, Hutson RA, Falsen E, Sjoden B. Facklamia sourekii sp. nov., isolated from human sources. Int J Syst Bacteriol. 1999;49(Pt 2):635–8.CrossRef
19.
Lawson PA, Collins MD, Falsen E, Sjoden B, Facklam RR. Facklamia languida sp. nov., isolated from human clinical specimens. J Clin Microbiol. 1999;37(4):1161–4.CrossRef
20.
Hoyles L, Foster G, Falsen E, Thomson LF, Collins MD. Facklamia miroungae sp. nov., from a juvenile southern elephant seal (Mirounga leonina). Int J Syst Evol Microbiol. 2001;51(Pt 4):1401–3.CrossRef
21.
Collins MD, Hutson RA, Falsen E, Sjoden B. Facklamia tabacinasalis sp. nov., from powdered tobacco. Int J Syst Bacteriol. 1999;49(Pt 3):1247–50.CrossRef
Metadata
Title
Facklamia hominis bacteremia after transurethral resection of the prostate: a case report
Authors
Miriam Gahl
Thomas Stöckli
René Fahrner
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00762-8

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue

Research article

Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer

Correction

Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

Case report

Atypical focal xanthogranulomatous pyelonephritis without clinical symptoms presenting as infiltrative renal cancer: a case report and literature review

Research article

Risk factors for incident delirium among urological patients: a systematic review and meta-analysis with GRADE summary of findings

Case report

Spontaneous vesicorectal fistula: a rare complication of neurogenic bladder

Research article

Systemic inflammatory response syndrome in patients with acute obstructive upper tract urinary stone: a risk factor for urgent renal drainage and revisit to the emergency department